Which stock is cheaper: DIVISLAB or LAURUSLABS?

Based on Price to Earnings, DIVISLAB trades at a P/E of 84.2 while LAURUSLABS trades at a P/E of 98.1.

Does DIVISLAB or LAURUSLABS have higher ROCE?

DIVISLAB generates an ROCE of 25.1% compared to LAURUSLABS's ROCE of 22.9%.

DIVI S LABORATORIES LTD (DIVISLAB) has a market cap of ₹2,47,470 Cr compared to LAURUS LABS LIMITED (LAURUSLABS) with ₹1,06,387 Cr.

DIVISLABHealthcare

Leads (3/5)

₹9,780.00+1.20%

Market Cap: ₹2,47,470 Cr

₹2,405.50+7.20%

Market Cap: ₹1,06,387 Cr

Automated quantitative breakdown of fundamental strengths between DIVISLAB and LAURUSLABS.

Attractive ValuationDIVISLAB (P/E 84.2)Trades at lower Price-to-Earnings

Capital EfficiencyDIVISLAB (ROCE 25.1%)Superior operating return on capital

Balance Sheet SafetyDIVISLABLower debt-to-equity ratio

Shareholder YieldLAURUSLABS (12.00%)Higher annual dividend yield

Green highlight indicates the stronger metric

Financial Metric	DIVISLAB	LAURUSLABS
Valuation Multiples
Market Capitalization	₹2,47,470 Cr	₹1,06,387 Cr
Price to Earnings (P/E)	84.21	98.07
Price to Book (P/B)	14.81	20.26
Profitability & Capital Efficiency
Return on Capital Employed (ROCE)	25.07%	22.85%
Return on Equity (ROE)	13.84%	9.46%
Operating Profit Margin (OPM)	34.38%	22.01%
Net Profit Margin (NPM)	26.17%	13.78%
Balance Sheet & Solvency
Debt to Equity Ratio	0.00	0.40
Dividend Yield	0.33%	12.00%
Historical Growth
3-Year Sales Growth (CAGR)	16.35%	22.60%
Latest Quarter Financial Results
Quarterly Revenue (30 Jun 2026)	₹3,080 Cr	₹2,026 Cr
Quarterly Net Profit	₹902 Cr	₹368 Cr